Inhibikase Therapeutics Inc
NASDAQ:IKT
Inhibikase Therapeutics Inc
NASDAQ:IKT
Price:
1.58
USD
-5.95%
Market Cap:
$191.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
I
|
Inmobiliaria Park Rose Iberoamericana SOCIMI SA
MAD:YPARK
|
ES |
|
S
|
SCB X PCL
SET:SCB
|
TH |
|
Union Technologies Informatique Group SA
PAR:FPG
|
FR |
|
Voltalia SA
PAR:VLTSA
|
FR |
|
P
|
Phoenix Holdings Ltd
TASE:PHOE
|
IL |
|
F
|
Fosun Tourism Group
HKEX:1992
|
CN |
|
Victoria Oil & Gas PLC
LSE:VOG
|
UK |
|
BGR Energy Systems Ltd
NSE:BGRENERGY
|
IN |
Multiples-Based Value
The
Multiples-Based Value for
Inhibikase Therapeutics Inc (IKT)
under the Base Case is
hidden
USD.
Compared with the current market price of 1.58 USD, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
IKT Multiples-Based Value
LOCKED
Multiples Across Competitors
IKT Competitors Multiples
Inhibikase Therapeutics Inc Competitors
Inhibikase Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
191.6m USD | 0 | -4 | -2.6 | -2.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD | 6.3 | 91.9 | 15.2 | 21.1 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
361.6B USD | 111.3 | -1 738.3 | 16 147.7 | -1 823.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD | 5.2 | 24.6 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD | 5.9 | 20.3 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.6B USD | 9.5 | 28.7 | 21.6 | 22.5 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.7 | 18.1 | 13.6 | 15.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD | 3.1 | 34.8 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
